Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Halo Collective Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Halo Collective şirketinin kazançları yıllık ortalama -48.7% oranında azalırken, Pharmaceuticals sektörünün kazançları yıllık 10.8% oranında artan oldu. Gelirler yıllık ortalama 23% oranında artan oldu.

Anahtar bilgiler

-48.7%

Kazanç büyüme oranı

61.1%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi	7.3%
Gelir büyüme oranı	23.0%
Özkaynak getirisi	-126.4%
Net Marj	-333.9%
Son Kazanç Güncellemesi	30 Sep 2022

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Halo Collective nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

BST:A9KN Gelir, gider ve kazançlar (USD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Sep 22	28	-95	38
30 Jun 22	32	-99	43
31 Mar 22	34	-99	44
31 Dec 21	36	-95	42
30 Sep 21	33	-54	39
30 Jun 21	31	-47	31
31 Mar 21	27	-42	25
31 Dec 20	22	-41	22
30 Sep 20	19	-33	24
30 Jun 20	20	-35	27
31 Mar 20	24	-33	26
31 Dec 19	28	-28	24
30 Sep 19	28	-17	17
30 Jun 19	25	-17	14
31 Mar 19	17	-15	11
31 Dec 18	11	-14	9
30 Sep 18	10	-15	11
30 Jun 18	10	-11	10
31 Mar 18	10	-10	10
31 Dec 17	10	-9	9
31 Dec 16	5	0	1

Kaliteli Kazançlar: A9KN şu anda kârlı değil.

Büyüyen Kar Marjı: A9KN şu anda kârlı değil.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: A9KN kârlı değildir ve zararlar son 5 yılda yılda 48.7% oranında artmıştır.

Büyüme Hızlandırma: A9KN 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: A9KN kârlı olmadığından, geçmiş yıl kazanç büyümesinin Pharmaceuticals sektörüyle ( 1.5% ) karşılaştırılması zorlaşıyor.

Özkaynak Getirisi

Yüksek ROE: A9KN hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -126.35% ) sahiptir.

Halo Collective Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Second quarter 2022 earnings released: US$1.61 loss per share (vs US$11.41 loss in 2Q 2021)

First quarter 2022 earnings released: US$0.28 loss per share (vs US$0.56 loss in 1Q 2021)

Full year 2021 earnings released: US$4.12 loss per share (vs US$7.27 loss in FY 2020)

Third quarter 2021 earnings released: US$0.40 loss per share (vs US$0.42 loss in 3Q 2020)

Third quarter 2020 earnings released: US$0.006 loss per share

Earnings released

Recent updates

Halo Collective Inc. Announces Change to Board of Directors

Halo Collective Inc. Announces Expansion of Cannabis Genetics and Strain Portfolio, Specifically Within Its Oregon Operations

Halo Collective Inc., Annual General Meeting, Mar 24, 2023

Halo Collective Inc. announced that it has received $6.99999 million in funding from Agilent Technologies, Inc., Research Corporation Technologies, BroadOak Capital Partners LLC, Investment Arm, BioAdvance, and other investors

Halo Collective Inc. Announces Launch of New Premium Cannabis Strains

Second quarter 2022 earnings released: US$1.61 loss per share (vs US$11.41 loss in 2Q 2021)

Halo Collective Inc. Appoints Katie Field as Chairman of the Board

Halo Collective Receives All Regulatory Approvals for Its Third Budega Dispensary in Hollywood, Halo's First Superstore

Halo Collective Inc. announced that it has received $6 million in funding from Agilent Technologies, Inc., Research Corporation Technologies, BroadOak Capital Partners LLC, Investment Arm, BioAdvance and other investors

Halo Collective Inc. announced that it has received $5.999994 million in funding

Halo Collective Inc. Announces Management Changes

First quarter 2022 earnings released: US$0.28 loss per share (vs US$0.56 loss in 1Q 2021)

Halo Collective Inc. Announces Resignation of Philip Van Den Berg as Chief Financial Officer

Halo Collective Inc. Receives Final Approvals from the Los Angeles Department of Cannabis Regulation & California Department of Cannabis Control and the State Department of Cannabis Control

High number of new directors

Full year 2021 earnings released: US$4.12 loss per share (vs US$7.27 loss in FY 2020)

Less than half of directors are independent

Halo Collective Announces Changes to Board of Directors

Halo Collective Inc. Receives All Approvals for Budega™ Dispensary in North Hollywood, California

Halo Collective Inc. Receives All Approvals for Budega™ Dispensary in North Hollywood, California

Halo Collective Inc. (OTCPK:HCAN.F) completed the acquisition of 1285826 B.C. Ltd. from 1337617 B.C. Ltd., 1253540 B.C. Ltd. and NKG Investments Ltd.

Halo Collective Inc. announced that it expects to receive CAD 14 million in funding from Alpha Blue Ocean Investment Group

Halo Collective Receives Local Approvals for Budega™ Dispensary in Los Angeles's Noho Arts District

Halo Collective Inc. (OTCPK:HCAN.F) entered into an agreement to acquire 1285826 B.C. Ltd. for $7 million.

Third quarter 2021 earnings released: US$0.40 loss per share (vs US$0.42 loss in 3Q 2020)

High number of new directors

High number of new directors

Halo Collective Inc. Announces the Official Launch of Ztrawberriez and 4 Prophets Premium Cannabis Flower

Halo Collective Inc. Announces FlowerShop, a Sensory-Care™ Brand Launches New Product Line, BUDVASE

Halo Collective Announces Reorganization of International Assets to Create Akanda

Halo Collective Inc. Provides Earnings Guidance for the Year 2021

Halo Collective Inc. Provides Sales Guidance for the Month Ended April 2021

Halo Collective Inc. announced that it expects to receive CAD 1 million in funding

Halo Collective Inc. has completed a Composite Units Offering in the amount of CAD 10.000025 million.

PeakBirch Logic Inc. Announces Partnership with Halo Collective Inc. to Develop Functional Mushroom Line

Halo Collective Inc. Enters into Partnership with Nightingale Remedies (Nightingale) and PeakBirch Logic Inc

Halo Collective Inc. has completed a Composite Units Offering in the amount of CAD 8.00154 million.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of 1275111 B.C. Ltd.

Halo Labs Inc. announced that it expects to receive CAD 2.25 million in funding

Chief Financial Officer recently sold €95k worth of stock

Red Light Holland and Halo Labs Announce Intention to Enter Oregon Medicinal Psilocybin Market

Third quarter 2020 earnings released: US$0.006 loss per share

Halo Labs Inc. Appoints Annmol Sidhu to the Board of Directors

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of CanMart Ltd from David Keith Dean and Darran William Quinn.

Fred Leigh Resigns to Halo Labs Inc.'s Board of Directors

Halo Labs Inc. (OTCPK:AGEE.F) entered into a binding Letter of Intent to acquire CanMart Ltd for CAD 4.6 million.

Halo Labs Inc. (OTCPK:AGEE.F) entered into an amended asset purchase agreement to acquire three operating KushBar retail cannabis stores from KushBar Inc. for CAD 3.4 million.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of 1265292 B.C. Ltd.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of the remaining 85.28% stake in Ukiah Ventures Inc. from Odyssey Trust Company and others.

Earnings released

Halo Labs Inc. (OTCPK:AGEE.F) entered into a share exchange agreement to acquire the remaining 85.28% stake in Ukiah Ventures Inc. for $6.5 million.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of 66.7% stake in LKJ11 LLC.

Halo Labs Inc. (OTCPK:AGEE.F) entered into a binding agreement to acquire a dispensary in Los Angeles.

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin